Center for Coronary Artery Disease

Science Center

Making the impossible possible through innovative research and education around treatment approaches for the most complex of coronary artery disease cases.

Minneapolis Heart Institute Foundation® (MHIF) has built its reputation as one of the nation’s most distinguished champions of coronary artery disease (CAD) research and treatment. Under the leadership of Dr. Emmanouil Brilakis, the Center for Coronary Artery Disease works to decrease the burden of CAD through research, innovation and education

MHIF’s Center for Coronary Artery Disease is strongly positioned for success through:

  • A partnership with 70+ cardiologists who see more than 31,000 individual patients at nearly 57,000 clinic visits each year at Abbott Northwestern Hospital (ANW) and 36 outreach sites
  • An exceptionally large and diverse patient experience complete with data contained within the electronic medical record as part of Allina Health
  • A proven track record of dissemination, publishing 188 manuscripts in 2017 in peer-reviewed journals and presenting novel

Research

Progress-CTO

PROspective Global Registry for the Study of CTO Interventions. Learn more from the multi-center registry of Chronic Total Occlusion Precutaneous Coronary Interventions.

Learn More

ASAP SVG

The pilot trial for Alirocumab for Stopping Atherosclerosis Progression in Saphenous Vein Grafts aims to improve the CABG patients’ quality and duration of life, reduce the need for repeat revascularization procedures, and potentially reduce their healthcare costs.

Learn More

Shine CTO

SHam-controlled INtErvention to Improve Quality of Life in CTOs (SHINE-CTO Trial). Provides novel insights into the most complex type of percutaneous coronary interventions, i.e. treatment of coronary chronic total occlusions (100% blockages that are >3 months old).

Learn More

REBIRTH

This is a randomized prospective trial that will compare Radial artery access to state-of-the-art Femoral artery access for Cardiac Catheterization and PCI procedures. The objective of this trial is to help determine the optimal method for obtaining arterial access in various clinical settings and improve patient outcomes.

Learn More

Education

Patients

By collaborating with other cardiology fields, such as non-invasive imaging, advanced heart failure and cardiac surgery, patients can be successfully treated, improving their quality, and often quantity, of life.

Learn More

Professionals

With several ongoing research and education projects, the Center for Coronary Disease (CCAD) is having a significant impact on the health of patients with complex coronary artery disease around the world.

CTO Manual 
PCI Manual
Learn More

News & Events

Stories of Gratitude

Lynn Hammrich: Chronic Total Occlusion

Lynn Hammrich is no stranger to heart disease and its impact on his family. At age 41,...

News

MHIF at CVI 2019

MHIF was well represented at the 2019 Cardiovascular Innovations conference in Denver, CO in July....

CCAD

MHIF at SCAI 2019

MHIF had several research physicians and staff attend the Society for Cardiovascular Angiography & Interventions...

Lynn Hammrich: Chronic Total Occlusion

Lynn Hammrich is no stranger to heart disease and its impact on his family. At age 41, he had his first heart attack, more than 20 years ago. Over...

MHIF at CVI 2019

MHIF was well represented at the 2019 Cardiovascular Innovations conference in Denver, CO in July. Dr. Paul Sorajja, Roger L. and Lynn C. Headrick Family Chair for Valve...

MHIF at SCAI 2019

MHIF had several research physicians and staff attend the Society for Cardiovascular Angiography & Interventions 2019 Scientific Sessions in Las Vegas, NV in May. Check out some...

Our Team

The Center for Coronary Artery Disease is an international leader in research and education on complex coronary artery disease.

Meet the team of physicians, scholars and staff
who help save lives every day.

Meet the Team

Contact Us

8 + 8 =